| Title |
Molden 2.0: quantum chemistry meets proteins
|
|---|---|
| Published in |
Perspectives in Drug Discovery and Design, July 2017
|
| DOI | 10.1007/s10822-017-0042-5 |
| Pubmed ID | |
| Authors |
Gijs Schaftenaar, Elias Vlieg, Gert Vriend |
| Abstract |
Since the first distribution of Molden in 1995 and the publication of the first article about this software in 2000 work on Molden has continued relentlessly. A few of the many improved or fully novel features such as improved and broadened support for quantum chemistry calculations, preparation of ligands for use in drug design related softwares, and working with proteins for the purpose of ligand docking. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 113 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 20 | 18% |
| Researcher | 16 | 14% |
| Student > Bachelor | 14 | 12% |
| Student > Master | 12 | 11% |
| Professor | 6 | 5% |
| Other | 17 | 15% |
| Unknown | 28 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Chemistry | 44 | 39% |
| Biochemistry, Genetics and Molecular Biology | 8 | 7% |
| Physics and Astronomy | 8 | 7% |
| Chemical Engineering | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 11 | 10% |
| Unknown | 35 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2017.
All research outputs
#22,963,239
of 25,604,262 outputs
Outputs from Perspectives in Drug Discovery and Design
#870
of 951 outputs
Outputs of similar age
#287,531
of 327,806 outputs
Outputs of similar age from Perspectives in Drug Discovery and Design
#12
of 15 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,806 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.